Search research articles
Contact Us
Filters
Showing results (381-390 of 428) with videos related to
Page
of 43
Sort By:
Haematologica
|
September 24, 2016
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
Andrew S Artz, Brent Logan, Xiaochun Zhu, et al.
Bone Marrow Transplantation
|
November 2, 2004
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma
A P Rapoport, C Guo, A Badros, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2014
Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources
Karen K Ballen, Steven Joffe, Ruta Brazauskas, et al.
Lancet (London, England)
|
August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
Benjamin A Fisher, Xavier Mariette, Athena Papas, et al.
Bone Marrow Transplantation
|
December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantation
G Akpek, M C Pasquini, B Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 21, 2014
Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation
César O Freytes, Juan J Toro, Rosa F Yeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 4, 2015
The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia
Jennifer L Holter-Chakrabarty, Namali Pierson, Mei-Jie Zhang, et al.
Blood
|
June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
Joseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
American Journal of Ophthalmology
|
November 23, 2025
TFOS DEWS III
Lyndon Jones, Jennifer P Craig, Maria Markoulli, et al.
American Journal of Ophthalmology
|
June 4, 2025
TFOS DEWS III: Management and Therapy
Lyndon Jones, Jennifer P Craig, Maria Markoulli, et al.
Page
of 43
Search research articles
Search
Showing results (381-390 of 428) with videos related to
Sort By:
Page
of 43
Haematologica
|
September 24, 2016
The prognostic value of serum C-reactive protein, ferritin, and albumin prior to allogeneic transplantation for acute myeloid leukemia and myelodysplastic syndromes
Andrew S Artz, Brent Logan, Xiaochun Zhu, et al.
Bone Marrow Transplantation
|
November 2, 2004
Autologous stem cell transplantation followed by consolidation chemotherapy for relapsed or refractory Hodgkin's lymphoma
A P Rapoport, C Guo, A Badros, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
July 28, 2014
Hospital length of stay in the first 100 days after allogeneic hematopoietic cell transplantation for acute leukemia in remission: comparison among alternative graft sources
Karen K Ballen, Steven Joffe, Ruta Brazauskas, et al.
Lancet (London, England)
|
August 3, 2024
Safety and efficacy of subcutaneous iscalimab (CFZ533) in two distinct populations of patients with Sjögren's disease (TWINSS): week 24 results of a randomised, double-blind, placebo-controlled, phase 2b dose-ranging study
Benjamin A Fisher, Xavier Mariette, Athena Papas, et al.
Bone Marrow Transplantation
|
December 11, 2012
Effects of spleen status on early outcomes after hematopoietic cell transplantation
G Akpek, M C Pasquini, B Logan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 21, 2014
Safety and efficacy of targeted-dose busulfan and bortezomib as a conditioning regimen for patients with relapsed multiple myeloma undergoing a second autologous blood progenitor cell transplantation
César O Freytes, Juan J Toro, Rosa F Yeh, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
April 4, 2015
The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia
Jennifer L Holter-Chakrabarty, Namali Pierson, Mei-Jie Zhang, et al.
Blood
|
June 15, 2016
Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial
Joseph C Alvarnas, Jennifer Le Rademacher, Yanli Wang, et al.
American Journal of Ophthalmology
|
November 23, 2025
TFOS DEWS III
Lyndon Jones, Jennifer P Craig, Maria Markoulli, et al.
American Journal of Ophthalmology
|
June 4, 2025
TFOS DEWS III: Management and Therapy
Lyndon Jones, Jennifer P Craig, Maria Markoulli, et al.
Page
of 43